缬沙坦联合黄葵胶囊对高血压合并Ⅱ型糖尿病肾病患者血压 血糖水平和肾脏的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:


Effect of valsartan combined with Huangkui capsule on blood pressure, blood sugar levels and kidneys in patients with hypertension complicated with type 2 diabetic nephropathy
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    【摘要】〓目的〓探讨缬沙坦联合黄葵胶囊对高血压合并Ⅱ型糖尿病肾病患者血压、血糖和肾功能的影响,为临床治疗提供参考依据。方法〓选取我院2014年1月~2016年6月收治的80例高血压合并Ⅱ型糖尿病肾病患者作为研究对象,根据随机数字表法分为观察组和对照组各40例,对照组给予缬沙坦治疗,观察组给予缬沙坦联合黄葵胶囊治疗,治疗8周后,比较两组患者的临床疗效以及血压、血糖、肾功能变化情况。结果〓治疗8周后,观察组总有效率明显高于对照组,组间差异有统计学意义(P<005);两组患者治疗后SBP、DBP、MAP、FBS、PBG2h、HbAIc、UAER、24hPro均明显低于治疗前(P<005);观察组SBP、DBP、MAP、FBS、PBG2h、HbAIc、UAER、24hPro均明显低于对照组,差异有统计学意义(P<005);两组患者不良反应发生率比较,差异无统计学意义(P>005)。结论〓缬沙坦联合黄葵胶囊提高了高血压合并Ⅱ型糖尿病肾病的治疗效果,改善了患者血压、血糖水平和肾功能,且未增加不良反应的发生率,可在临床推广应用。

    Abstract:

    【Abstract】Objective To investigate the effect of valsartan combined with Huangkui capsule on Blood pressure, blood sugar levels and renal function in patients with hypertension complicated with type 2 diabetic nephropathy, to provide reference for clinical treatment. Methods〓80 patients with hypertension complicated with type 2 diabetic nephropathy from January 2014 to June 2016 in our hospital were selected. According to the random number table method, the patients were divided into observation group and control group, each of 40 cases. The control group was treated with valsartan. The observation group was treated with valsartan combined with Huangkui capsule. After 8 weeks of treatment, the clinical efficacy and blood pressure, blood glucose, renal function were compared between the two groups. Results〓After 8 weeks of treatment, the total effective rate of the observation group was significantly higher than that of the control group. The difference was statistically significant (P<005). SBP, DBP, MAP,FBS, PBG2h, HbAIc, UAER and 24hPro were all significantly lower in the 2 groups after treatment than before treatment (P<005). SBP, DBP, MAP, FBS, PBG2h, HbAIc, UAER and 24hPro of the observation group was significantly lower than that of the control group. The difference was statistically significant (P<005). There was no significant difference in the incidence of adverse reactions between the 2 groups (P>005). Conclusion〓The effect of valsartan combined with Huangkui capsule improves blood pressure associated with type 2 diabetic nephropathy treatment effect, improve the blood pressure, blood glucose and renal function, and did not increase the incidence of adverse reactions.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2017-11-10
您是第位访问者
版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司